Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversitas Muhammadiyah Surakarta
About this trial
This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.
Eligibility criteria
Qualifiers
Patients diagnosed with stage V chronic kidney disease.
Undergoing scheduled hemodialysis at least twice a week for 6 weeks.
Outpatients and aged 18-65 years.
Muslim.
Disqualifiers
Having a severe heart condition or an unstable critical condition.
Having a severe psychiatric disorder (schizophrenia, major depression).
Having a cognitive, hearing, or speech disorder that impedes communication.
Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.
Trial design
Treatments tested in this trial
- Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy
- listening to dangdut music
Treatment groups
76 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov